Skip to main content
SpringerLink
Log in
Book cover

Current Advances in Osteosarcoma pp 147–160Cite as

Autophagy in Osteosarcoma

  • Chapter
  • First Online:

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 804))

Abstract

Osteosarcoma (OS) metastatic disease is resistant to conventional chemotherapy. Tumor resistance to chemotherapy has been one of the major areas of concern to clinicians and the topic of many laboratory investigators. Evaluation of mechanisms implicated in OS lung metastasis resistance to chemotherapy has been the focus of some of our most recent work. We have previously demonstrated the therapeutic efficacy of aerosol gemcitabine (GCB) in OS lung metastases. However, a subset of cells fails to respond to GCB treatment and persists as isolated lung metastases in vivo. Autophagy, a physiological mechanism that supports nutritional deprivation under stressful conditions, has been implicated in tumor resistance to chemotherapy. We demonstrated the induction of autophagy by GCB in LM7 metastatic human OS cells and K7M3 metastatic murine OS cells. Inhibition of autophagy resulted in increased sensitivity to GCB in LM7 cells. By contrast, inhibiting autophagy in K7M3 cells decreased GCB sensitivity. Defining the role autophagy plays in chemotherapy response in different tumor types has become of greater importance in order to identify the best suitable therapeutic approach. In this chapter, we summarize some of the most recent work related to autophagy in OS, identify some of the known mechanisms, and address the different roles autophagy plays in chemotherapy response.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Gordon N, Kleinerman ES (2009) The role of Fas/FasL in the metastatic potential of osteosarcoma and targeting this pathway for the treatment of osteosarcoma lung metastases. Cancer Treat Res 152:497–508. doi:10.1007/978-1-4419-0284-9_29

    Article  PubMed  Google Scholar 

  2. Duprez L, Wirawan E, Vanden Berghe T, Vandenabeele P (2009) Major cell death pathways at a glance. Microbes Infect 11(13):1050–1062. doi:10.1016/j.micinf.2009.08.013

    Article  PubMed  CAS  Google Scholar 

  3. Gozuacik D, Kimchi A (2004) Autophagy as a cell death and tumor suppressor mechanism. Oncogene 23(16):2891–2906. doi:10.1038/sj.onc.1207521

    Article  PubMed  CAS  Google Scholar 

  4. Shen HM, Codogno P (2011) Autophagic cell death: Loch Ness monster or endangered species? Autophagy 7(5):457–465

    Article  PubMed  CAS  Google Scholar 

  5. Aredia FGL, Giansanti V, Scovassi AI (2012) Autophagy and cancer. Cells 1(3):520–534

    Article  PubMed  PubMed Central  Google Scholar 

  6. Sun Y, Peng ZL (2009) Programmed cell death and cancer. Postgrad Med J 85(1001):134–140. doi:10.1136/pgmj.2008.072629

    Article  PubMed  CAS  Google Scholar 

  7. Yang ZJ, Chee CE, Huang S, Sinicrope FA (2011) The role of autophagy in cancer: therapeutic implications. Mol Cancer Ther 10(9):1533–1541. doi:10.1158/1535-7163.MCT-11-0047

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  8. Liu EY, Ryan KM (2012) Autophagy and cancer—issues we need to digest. J Cell Sci 125(Pt 10):2349–2358. doi:10.1242/jcs.093708

    Article  PubMed  Google Scholar 

  9. Huber A, Rubio A, Loewith RJ (2009) Mammalian target of rapamycin signaling and cancer treatment. Cancer Chemother Rev 4(4):210–223

    Google Scholar 

  10. Liu Q, Thoreen C, Wang J, Sabatini D, Gray NS (2009) MTOR mediated anti-cancer drug discovery. Drug Discov Today Ther Strat 6(2):47–55, http://dx.doi.org/10.1016/j.ddstr.2009.12.001

    Article  CAS  Google Scholar 

  11. Kang R, Zeh HJ, Lotze MT, Tang D (2011) The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ 18(4):571–580. doi:10.1038/cdd.2010.191

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  12. Pattingre S, Tassa A, Qu X, Garuti R, Liang XH, Mizushima N, Packer M, Schneider MD, Levine B (2005) Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 122(6):927–939. doi:10.1016/j.cell.2005.07.002

    Article  PubMed  CAS  Google Scholar 

  13. Furuya N, Yu J, Byfield M, Pattingre S, Levine B (2005) The evolutionarily conserved domain of Beclin 1 is required for Vps34 binding, autophagy and tumor suppressor function. Autophagy 1(1):46–52

    Article  PubMed  CAS  Google Scholar 

  14. Ciechomska IA, Goemans GC, Skepper JN, Tolkovsky AM (2009) Bcl-2 complexed with Beclin-1 maintains full anti-apoptotic function. Oncogene 28(21):2128–2141. doi:10.1038/onc.2009.60

    Article  PubMed  CAS  Google Scholar 

  15. Boya P, Kroemer G (2009) Beclin 1: a BH3-only protein that fails to induce apoptosis. Oncogene 28(21):2125–2127. doi:10.1038/onc.2009.83

    Article  PubMed  CAS  Google Scholar 

  16. Sun Q, Fan W, Chen K, Ding X, Chen S, Zhong Q (2008) Identification of Barkor as a mammalian autophagy-specific factor for Beclin 1 and class III phosphatidylinositol 3-kinase. Proc Natl Acad Sci U S A 105(49):19211–19216. doi:10.1073/pnas.0810452105

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  17. Lorin S, Borges A, Dos Santos LR, Souquere S, Pierron G, Ryan KM, Codogno P, Djavaheri-Mergny M (2009) c-Jun NH2-terminal kinase activation is essential for DRAM-dependent induction of autophagy and apoptosis in 2-methoxyestradiol-treated ewing sarcoma cells. Cancer Res 69(17):6924–6931, http://dx.doi.org/10.1158/0008-5472.CAN-09-1270

    Article  PubMed  CAS  Google Scholar 

  18. Pursiheimo JP, Rantanen K, Heikkinen PT, Johansen T, Jaakkola PM (2009) Hypoxia-activated autophagy accelerates degradation of SQSTM1/p62. Oncogene 28(3):334–344. doi:10.1038/onc.2008.392

    Article  PubMed  CAS  Google Scholar 

  19. Noman MZ, Janji B, Berchem G, Mami-Chouaib F, Chouaib S (2012) Hypoxia-induced autophagy: a new player in cancer immunotherapy? Autophagy 8(4):704–706. doi:10.4161/auto.19572

    Article  PubMed  CAS  Google Scholar 

  20. Jiang H, Martin V, Gomez-Manzano C, Johnson DG, Alonso M, White E, Xu J, McDonnell TJ, Shinojima N, Fueyo J (2010) The RB-E2F1 pathway regulates autophagy. Cancer Res 70(20):7882–7893. doi:10.1158/0008-5472.can-10-1604

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  21. Coupienne I, Fettweis G, Piette J (2011) RIP3 expression induces a death profile change in U2OS osteosarcoma cells after 5-ALA-PDT. Lasers Surg Med 43(7):557–564. doi:10.1002/lsm.21088

    PubMed  Google Scholar 

  22. Huang J, Liu K, Yu Y, Xie M, Kang R, Vernon P, Cao L, Tang D, Ni J (2012) Targeting HMGB1-mediated autophagy as a novel therapeutic strategy for osteosarcoma. Autophagy 8(2):275–277. doi:10.4161/auto.8.2.18940

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  23. Huang J, Ni J, Liu K, Yu Y, Xie M, Kang R, Vernon P, Cao L, Tang D (2012) HMGB1 promotes drug resistance in osteosarcoma. Cancer Res 72(1):230–238. doi:10.1158/0008-5472.can-11-2001

    Article  PubMed  CAS  Google Scholar 

  24. Wong W (2013) Inhibit autophagy, STAT! Sci Signal 6(256):ec4, http://dx.doi.org/10.1126/scisignal.2003913

    Article  Google Scholar 

  25. Roy S, Debnath J (2010) Autophagy and tumorigenesis. Semin Immunopathol 32(4):383–396. doi:10.1007/s00281-010-0213-0

    Article  PubMed  PubMed Central  Google Scholar 

  26. Chen N, Debnath J (2010) Autophagy and tumorigenesis. FEBS Lett 584(7):1427–1435. doi:10.1016/j.febslet.2009.12.034

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  27. Pardo R, Lo Re A, Archange C, Ropolo A, Papademetrio DL, Gonzalez CD, Alvarez EM, Iovanna JL, Vaccaro MI (2010) Gemcitabine induces the VMP1-mediated autophagy pathway to promote apoptotic death in human pancreatic cancer cells. Pancreatology 10(1):19–26. doi:10.1159/000264680

    Article  PubMed  CAS  Google Scholar 

  28. Eskelinen EL (2011) The dual role of autophagy in cancer. Curr Opin Pharmacol 11(4):294–300. doi:10.1016/j.coph.2011.03.009

    Article  PubMed  CAS  Google Scholar 

  29. Akin D, Law B, Progulske-fox A, Dunn WA (2009) Identification of compounds that enhance and suppress autophagy. Autophagy 5(6):910–911

    Google Scholar 

  30. Notte A, Leclere L, Michiels C (2011) Autophagy as a mediator of chemotherapy-induced cell death in cancer. Biochem Pharmacol 82(5):427–434. doi:10.1016/j.bcp.2011.06.015

    Article  PubMed  CAS  Google Scholar 

  31. Shao Y, Gao Z, Marks PA, Jiang X (2004) Apoptotic and autophagic cell death induced by histone deacetylase inhibitors. Proc Natl Acad Sci U S A 101(52):18030–18035. doi:10.1073/pnas.0408345102

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  32. Periyasamy-Thandavan S, Jiang M, Schoenlein P, Dong Z (2009) Autophagy: molecular machinery, regulation, and implications for renal pathophysiology. Am J Physiol Renal Physiol 297(2):F244–F256. doi:10.1152/ajprenal.00033.2009

    Article  PubMed  CAS  Google Scholar 

  33. Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH, Blagosklonny MV, El-Deiry WS, Golstein P, Green DR, Hengartner M, Knight RA, Kumar S, Lipton SA, Malorni W, Nunez G, Peter ME, Tschopp J, Yuan J, Piacentini M, Zhivotovsky B, Melino G (2009) Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ 16(1):3–11. doi:10.1038/cdd.2008.150

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  34. Le XF, Mao W, Lu Z, Carter BZ, Bast RC Jr (2010) Dasatinib induces autophagic cell death in human ovarian cancer. Cancer 116(21):4980–4990. doi:10.1002/cncr.25426

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  35. Seibenhener ML, Geetha T, Wooten MW (2007) Sequestosome 1/p62—more than just a scaffold. FEBS Lett 581(2):175–179. doi:10.1016/j.febslet.2006.12.027

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  36. Komatsu M, Ichimura Y (2010) Physiological significance of selective degradation of p62 by autophagy. FEBS Lett 584(7):1374–1378. doi:10.1016/j.febslet.2010.02.017

    Article  PubMed  CAS  Google Scholar 

  37. Ichimura Y, Komatsu M (2010) Selective degradation of p62 by autophagy. Semin Immunopathol 32(4):431–436. doi:10.1007/s00281-010-0220-1

    Article  PubMed  Google Scholar 

  38. Rebucci M, Michiels C (2013) Molecular aspects of cancer cell resistance to chemotherapy. Biochem Pharmacol 85(9):1219–1226. doi:10.1016/j.bcp.2013.02.017

    Article  PubMed  CAS  Google Scholar 

  39. Doroshow JH (2013) Overcoming resistance to targeted anticancer drugs. N Engl J Med 369(19):1852–1853. doi:10.1056/NEJMe1311325

    Article  PubMed  CAS  Google Scholar 

  40. Luqmani YA (2005) Mechanisms of drug resistance in cancer chemotherapy. Med Princ Pract 14(Suppl 1):35–48. doi:10.1159/000086183

    Article  PubMed  Google Scholar 

  41. Gillet JP, Gottesman MM (2010) Mechanisms of multidrug resistance in cancer. Methods Mol Biol 596:47–76. doi:10.1007/978-1-60761-416-6_4

    Article  PubMed  CAS  Google Scholar 

  42. Rufini A, Melino G (2011) Cell death pathology: the war against cancer. Biochem Biophys Res Commun 414(3):445–450, http://dx.doi.org/10.1016/j.bbrc.2011.09.110

    Article  PubMed  CAS  Google Scholar 

  43. Meschini S, Condello M, Marra M, Formisano G, Federici E, Arancia G (2007) Autophagy-mediated chemosensitizing effect of the plant alkaloid voacamine on multidrug resistant cells. Toxicol In Vitro 21(2):197–203. doi:10.1016/j.tiv.2006.09.007

    Article  PubMed  CAS  Google Scholar 

  44. Meschini S, Condello M, Calcabrini A, Marra M, Formisano G, Lista P, De Milito A, Federici E, Arancia G (2008) The plant alkaloid voacamine induces apoptosis-independent autophagic cell death on both sensitive and multidrug resistant human osteosarcoma cells. Autophagy 4(8):1020–1033

    Article  PubMed  CAS  Google Scholar 

  45. Dhule SS, Penfornis P, Frazier T, Walker R, Tan G, He J, John V, Pochampally R (2011) Curcumin in cyclodextrin in liposome as a delivery vehicle against osteosarcoma. Cancer Res http://dx.doi.org/10.1158/1538-7445.AM2011-4227

  46. Li X, Wu WK, Sun B, Cui M, Liu S, Gao J, Lou H (2011) Dihydroptychantol A, a macrocyclic bisbibenzyl derivative, induces autophagy and following apoptosis associated with p53 pathway in human osteosarcoma U2OS cells. Toxicol Appl Pharmacol 251(2):146–154. doi:10.1016/j.taap.2010.12.007

    Article  PubMed  CAS  Google Scholar 

  47. Ma D, Tremblay P, Mahngar K, Collins J, Hudlicky T, Pandey S (2011) Selective cytotoxicity against human osteosarcoma cells by a novel synthetic C-1 analogue of 7-deoxypancratistatin is potentiated by curcumin. PLoS One 6(12). http://dx.doi.org/10.1371/journal.pone.0028780

  48. Bechara A, Pereira GJS, Paredes-Gamero EJ, Barbosa CMV, Nascimento FD, Hirata H, Caires ACF, Smaili SS, Bincoletto C (2011) Autophagy and apoptosis modulation in osteosarcoma cells exposed to a new palladacycle compound. Basic Clin Pharmacol Toxicol 109:59, http://dx.doi.org/10.1111/j.1742-7843.2011.00722.x

    Google Scholar 

  49. Calvaruso G, Pellerito O, Notaro A, Giuliano M (2012) Cannabinoid-associated cell death mechanisms in tumor models (review). Int J Oncol 41(2):407–413, http://dx.doi.org/10.3892/ijo.2012.1476

    PubMed  CAS  Google Scholar 

  50. Pan J, Cheng C, Verstovsek S, Chen Q, Jin Y, Cao Q (2010) The BH3-mimetic GX15-070 induces autophagy, potentiates the cytotoxicity of carboplatin and 5-fluorouracil in esophageal carcinoma cells. Cancer Lett 293(2):167–174. doi:10.1016/j.canlet.2010.01.006

    Article  PubMed  CAS  Google Scholar 

  51. Urquiza L, Zalacain M, Marrodan L, Odero MD, Lecanda F, Gomez-Manzano C, Fueyo J, Sierrasesumaga L, Patino-Garcia A, Alonso MM (2011) Enhancing autophagy as a novel approach to target osteosarcoma: combination of oncolytic adenovirus and chemotherapy. Cancer Res. http://dx.doi.org/10.1158/1538-7445.AM2011-5402

  52. Lambert LA, Qiao N, Hunt KK, Lambert DH, Mills GB, Meijer L, Keyomarsi K (2008) Autophagy: a novel mechanism of synergistic cytotoxicity between doxorubicin and roscovitine in a sarcoma model. Cancer Res 68(19):7966–7974, http://dx.doi.org/10.1158/0008-5472.CAN-08-1333

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  53. Zhang Z, Shao Z, Xiong L, Che B, Deng C, Xu W (2009) Expression of Beclin1 in osteosarcoma and the effects of down-regulation of autophagy on the chemotherapeutic sensitivity. J Huazhong Univ Sci Technolog Med Sci 29(6):737–740. doi:10.1007/s11596-009-0613-3

    Article  PubMed  CAS  Google Scholar 

  54. Gordon N, Kleinerman ES (2010) Aerosol therapy for the treatment of osteosarcoma lung metastases: targeting the Fas/FasL pathway and rationale for the use of gemcitabine. J Aerosol Med Pulm Drug Deliv 23(4):189–196. doi:10.1089/jamp.2009.0812

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  55. Santiago-O’Farril (2013) in progress

    Google Scholar 

Download references

Acknowledgements

We are grateful to Amy A. Sisson from the UT MD Anderson Research Medical library for her clerical assistance.

Author information

Authors and Affiliations

  1. Department of Pediatrics-Research, The Children’s Cancer Hospital, University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA

    Janice Santiago O’Farrill & Nancy Gordon

Authors
  1. Janice Santiago O’Farrill
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nancy Gordon
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nancy Gordon .

Editor information

Editors and Affiliations

  1. Division of Pediatrics, Department of Cancer Biology, The Mary V. and John A. Reilly Distinguished Chair, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

    Eugenie S. Kleinerman, M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer International Publishing Switzerland

About this chapter

Cite this chapter

O’Farrill, J.S., Gordon, N. (2014). Autophagy in Osteosarcoma. In: Kleinerman, M.D., E. (eds) Current Advances in Osteosarcoma. Advances in Experimental Medicine and Biology, vol 804. Springer, Cham. https://doi.org/10.1007/978-3-319-04843-7_8

Download citation

Publish with us

Policies and ethics

Search

Navigation